The World Health Organization on Tuesday advised pregnant women not to travel to areas with ongoing Zika outbreaks, strengthening its guidance as laboratory and epidemiological evidence increasingly points toward a connection between the virus, fetal brain abnormalities and neurological illness.
An emergency committee convened under international health regulations kept the cluster of microcephaly and other neurological disorders classified as a global public health emergency. The panel did not declare that Zika has been proved to cause those conditions, but said the evidence of an association has grown and that governments should act before every causal question is resolved.
In its formal statement after the March 8 meeting, WHO recommended that pregnant women avoid travel to areas of active transmission and that those whose partners live in or visit such areas use safer sexual practices or abstain throughout pregnancy. The guidance recognizes two pathways of concern: mosquito-borne infection across a widening region and evidence that the virus can also pass through sexual contact.
Public Health Action Moves Ahead of Final Proof
Zika usually causes no symptoms or a mild illness marked by rash, fever, joint pain and red eyes. The emergency arises from an unusual rise in babies born with microcephaly in Brazil and reports of Guillain-Barré syndrome, a disorder in which the immune system attacks nerves and can cause paralysis.
Those patterns establish a strong reason for investigation but not, by themselves, proof of cause. Areas experiencing Zika transmission may differ in other exposures, and microcephaly definitions and reporting practices have varied. Researchers must determine whether the timing of infection, the viral strain, prior immunity or other factors affect risk.
WHO Director-General Margaret Chan said after the meeting that evidence for a likely relationship had become stronger. Her remarks to the media stressed that experts had identified studies still needed for causal certainty while warning that protective measures should not wait for definitive proof.
That approach follows a standard principle in outbreak control: when potential harm is severe and prevention carries relatively low cost, officials may recommend precautions despite uncertainty. The challenge is communicating risk without implying either that every infection produces birth defects or that uncertainty means no danger exists.
Laboratory Studies Identify a Plausible Mechanism
One of the most important recent advances came from researchers at Johns Hopkins, Florida State and Emory universities. They exposed three types of human cells to Zika virus and found that it preferentially infected cortical neural progenitor cells, which help build the cerebral cortex during fetal development.
The peer-reviewed Cell Stem Cell study found that infected progenitor cells produced more virus, experienced increased cell death and showed disrupted cell-cycle progression. The experiment used a laboratory strain and cultured cells rather than a developing fetus, so it cannot establish how often infection produces microcephaly in pregnancy. But it supplies a biologically plausible route from maternal infection to impaired brain growth.
A Johns Hopkins account of the work explained that the team compared neural progenitors with induced pluripotent stem cells and immature neurons. The preferential damage to the cells responsible for generating neurons makes the result more specific than a finding that the virus harms all cells equally.
Earlier clinical evidence pointed in the same direction. A New England Journal of Medicine discussion of a fetal case described Zika virus found in brain tissue after a pregnancy affected by severe microcephaly. Its authors cautioned that a single case cannot prove causation, yet the location of the virus and the pattern of injury strengthened the concern raised by Brazil’s population-level reports.
Travel and Sexual Transmission Change Clinical Advice
The new travel recommendation is narrower than a general ban. WHO is not advising countries to restrict commerce or ordinary travel to affected regions. It is directing pregnant women away from an exposure that may have irreversible fetal consequences and asking health systems to counsel families clearly.
Reuters reported that WHO officials characterized sexual transmission as more common than initially assumed. Confirmed and probable cases remain far fewer than mosquito-borne infections, but semen may carry virus after symptoms have ended. For a pregnant woman whose partner has been exposed, that creates a risk even without her own travel.
Clinical decisions are complicated by testing limitations. Most infected people do not become noticeably ill, and the window for detecting viral genetic material in blood can be short. Antibody tests may react to related flaviviruses such as dengue, which circulate in many of the same regions. A negative result therefore cannot always eliminate risk, and a positive screening result may require confirmatory testing.
U.S. experience remains limited but instructive. A Centers for Disease Control and Prevention report identified nine pregnant travelers with confirmed Zika infection as of February 17 and another 10 reports under investigation. The pregnancies had varied outcomes, underscoring both the seriousness of concern and the inability to predict an individual result from exposure alone.
Preparedness Must Join Surveillance With Care
WHO’s committee called for intensified surveillance of microcephaly and Guillain-Barré syndrome, stronger mosquito control, faster diagnostic development, and research using consistent definitions. Standardization is essential: if countries measure infant head circumference differently or investigate only the most severe cases, pooled data can misstate the association.
Health systems in affected areas must also prepare for practical consequences. Prenatal care will require detailed travel histories, ultrasound capacity and access to laboratory consultation. Neurology and rehabilitation services may face more suspected Guillain-Barré cases. Families confronting abnormal fetal findings will need counseling that distinguishes what is known from what remains uncertain.
The response cannot depend entirely on individual behavior. Aedes aegypti mosquitoes breed in small containers around homes, bite during the day and are difficult to suppress with bed nets alone. Municipal sanitation, removal of standing water, targeted insecticide use and community participation all matter. Women may be unable to avoid exposure if housing lacks screens or reliable water service forces storage in open containers.
The March meeting marks a shift in the weight of evidence, not the end of inquiry. Epidemiological comparisons must quantify risk by stage of pregnancy. Laboratory models must show whether currently circulating strains behave similarly. Researchers need reliable tests and studies that distinguish coincidence from causation.
For pregnant women and their clinicians, however, the operational message is already firmer. Avoid outbreak areas where possible, prevent mosquito bites when exposure cannot be avoided, and reduce sexual transmission throughout pregnancy when a partner may have encountered the virus. WHO has concluded that waiting for perfect certainty would carry a greater danger than acting on the evidence now in hand.
